These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36114577)

  • 1. Formal mindfulness practice predicts reductions in PTSD symptom severity following a mindfulness-based intervention for women with co-occurring PTSD and substance use disorder.
    Somohano VC; Kaplan J; Newman AG; O'Neil M; Lovejoy T
    Addict Sci Clin Pract; 2022 Sep; 17(1):51. PubMed ID: 36114577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trauma-Integrated Mindfulness-Based Relapse Prevention for Women with Comorbid Post-Traumatic Stress Disorder and Substance Use Disorder: A Cluster Randomized Controlled Feasibility and Acceptability Trial.
    Somohano VC; Bowen S
    J Integr Complement Med; 2022 Sep; 28(9):729-738. PubMed ID: 35648046
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder.
    Vrana C; Killeen T; Brant V; Mastrogiovanni J; Baker NL
    Contemp Clin Trials; 2017 Oct; 61():108-114. PubMed ID: 28765006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A treatment development study of a cognitive and mindfulness-based therapy for adolescents with co-occurring post-traumatic stress and substance use disorder.
    Fortuna LR; Porche MV; Padilla A
    Psychol Psychother; 2018 Mar; 91(1):42-62. PubMed ID: 28815876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mindfulness as a predictor of cognitive-behavioral therapy outcomes in inner-city adults with posttraumatic stress and substance dependence.
    Vujanovic AA; Smith LJ; Green C; Lane SD; Schmitz JM
    Addict Behav; 2020 May; 104():106283. PubMed ID: 31927220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Treatment Completion among Women Receiving Integrated Treatment for Comorbid Posttraumatic Stress and Substance Use Disorders.
    Killeen TK; Wen CC; Neelon B; Baker N
    Subst Use Misuse; 2023; 58(4):500-511. PubMed ID: 36705433
    [No Abstract]   [Full Text] [Related]  

  • 7. PTSD Symptom Clusters and Craving Differs by Primary Drug of Choice.
    Somohano VC; Rehder KL; Dingle T; Shank T; Bowen S
    J Dual Diagn; 2019; 15(4):233-242. PubMed ID: 31304887
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating posttraumatic stress disorder in substance use disorder patients with co-occurring posttraumatic stress disorder: study protocol for a randomized controlled trial to compare the effectiveness of different types and timings of treatment.
    Lortye SA; Will JP; Marquenie LA; Goudriaan AE; Arntz A; de Waal MM
    BMC Psychiatry; 2021 Sep; 21(1):442. PubMed ID: 34493253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mindfulness-based interventions for substance use disorders.
    Goldberg SB; Pace B; Griskaitis M; Willutzki R; Skoetz N; Thoenes S; Zgierska AE; Rösner S
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD011723. PubMed ID: 34668188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
    Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
    Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cognitive processing therapy-based treatment program for veterans diagnosed with co-occurring posttraumatic stress disorder and substance use disorder: The relationship between trauma-related cognitions and outcomes of a 6-week treatment program.
    Peck KR; Coffey SF; McGuire AP; Voluse AC; Connolly KM
    J Anxiety Disord; 2018 Oct; 59():34-41. PubMed ID: 30248534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel, integrated cognitive-behavioral therapy for co-occurring posttraumatic stress and substance use disorders: A pilot randomized clinical trial.
    Vujanovic AA; Smith LJ; Green CE; Lane SD; Schmitz JM
    Contemp Clin Trials; 2018 Feb; 65():123-129. PubMed ID: 29287668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.
    Roberts NP; Roberts PA; Jones N; Bisson JI
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010204. PubMed ID: 27040448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Exposure-Based Risk Reduction Through Family Therapy for Co-occurring Substance Use Problems and Posttraumatic Stress Disorder Symptoms Among Adolescents: A Randomized Clinical Trial.
    Danielson CK; Adams Z; McCart MR; Chapman JE; Sheidow AJ; Walker J; Smalling A; de Arellano MA
    JAMA Psychiatry; 2020 Jun; 77(6):574-586. PubMed ID: 32022827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTSD Avoidance Symptoms Associated With Alcohol Craving in Treatment-Seeking Veteran Population.
    Flynn AJ; Navarro GY; Basehore HK
    J Dual Diagn; 2022; 18(3):135-143. PubMed ID: 35761472
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Pretreatment Expectancy on Substance Use Outcomes in Women Mandated to Mindfulness-Based Relapse Prevention.
    Somohano VC; Shank T; Manuel J; Mallik D; Rehder K; Bowen S
    J Altern Complement Med; 2021 Dec; 27(12):1147-1155. PubMed ID: 34516782
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathways to change: Use trajectories following trauma-informed treatment of women with co-occurring post-traumatic stress disorder and substance use disorders.
    López-Castro T; Hu MC; Papini S; Ruglass LM; Hien DA
    Drug Alcohol Rev; 2015 May; 34(3):242-51. PubMed ID: 25735200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of trauma characteristics on post-traumatic stress disorder and substance use disorder outcomes across integrated and substance use treatments.
    Fitzpatrick S; Saraiya T; Lopez-Castro T; Ruglass LM; Hien D
    J Subst Abuse Treat; 2020 Jun; 113():107976. PubMed ID: 32059924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of therapeutic alliance, treatment feedback, and clinical outcomes among African American women in treatment for co-occurring PTSD and SUD.
    Bauer AG; Ruglass LM; Shevorykin A; Saraiya TC; Robinson G; Cadet K; Julien L; Chao T; Hien D
    J Subst Abuse Treat; 2022 Aug; 139():108766. PubMed ID: 35346534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes?
    Jeffirs SM; Jarnecke AM; Flanagan JC; Killeen TK; Laffey TF; Back SE
    Drug Alcohol Depend; 2019 Jun; 199():70-75. PubMed ID: 31009834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.